Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406) - Concepedia

Concepedia

Publication | Open Access

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

DOI Full Paper Access

381

Citations

28

References

2020

Year

Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Heinz‐Josef Lenz, Anthony M. Magliocco, Dipen M. Maru, Yibing Yan, Richard B. Lanman, Ganiraju C. Manyam, David S. Hong,

Journal of Clinical Oncology

Abstract

Simultaneous inhibition of EGFR and BRAF combined with irinotecan is effective in <i>BRAF</i><sup><i>V600E</i></sup>-mutated CRC.

References

	Year	Citations

Page 1